• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素对 S6K1 表达的调节在控制乳腺癌细胞增殖中形成了一个正反馈调节环。

Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.

机构信息

Department of Biology, Stern College for Women of Yeshiva University, New York, NY, USA.

出版信息

Oncogene. 2012 Dec 6;31(49):5073-80. doi: 10.1038/onc.2011.657. Epub 2012 Jan 30.

DOI:10.1038/onc.2011.657
PMID:22286763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3342462/
Abstract

The 40S ribosomal S6 kinase 1 (S6K1) is an important regulator of cell growth. Expression of S6K1 is often elevated in breast cancer cells. However, the transcriptional mechanism of S6K1 overexpression is not understood. In this report, we demonstrate that estrogen activates expression of S6K1 via estrogen receptor (ER)α in ER-positive breast cancer cells. We also show that estrogen acts on the proximal promoter of the S6K1 gene in a mechanism involving the transcriptional factor GATA-3. Finally, we provide data that support the importance of estrogenic regulation of S6K1 expression in breast cancer cell proliferation. S6K1 directly phosphorylates and regulates ligand-independent activity of ERα, while ERα upregulates S6K1 expression. This S6K1-ERα relationship creates a positive feed-forward loop in control of breast cancer cell proliferation. Furthermore, the co-dependent association between S6K1 and ERα may be exploited in the development of targeted breast cancer therapies.

摘要

40S 核糖体 S6 激酶 1(S6K1)是细胞生长的重要调节因子。S6K1 的表达在乳腺癌细胞中常常升高。然而,S6K1 过表达的转录机制尚不清楚。在本报告中,我们证明雌激素通过 ER 阳性乳腺癌细胞中的雌激素受体(ER)α激活 S6K1 的表达。我们还表明,雌激素通过涉及转录因子 GATA-3 的机制作用于 S6K1 基因的近端启动子。最后,我们提供的数据支持雌激素对 S6K1 表达在乳腺癌细胞增殖中的调节作用的重要性。S6K1 直接磷酸化并调节 ERα 的配体非依赖性活性,而 ERα 上调 S6K1 的表达。这种 S6K1-ERα 关系在控制乳腺癌细胞增殖中形成了一个正反馈回路。此外,S6K1 和 ERα 之间的协同关联可能会被利用于开发针对乳腺癌的靶向治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/b4f795a7b6fb/nihms346261f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/72a96744849c/nihms346261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/0ebfb246de49/nihms346261f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/6d4ab0888a9f/nihms346261f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/6c49e8fe91d3/nihms346261f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/ddd14371b841/nihms346261f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/b4f795a7b6fb/nihms346261f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/72a96744849c/nihms346261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/0ebfb246de49/nihms346261f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/6d4ab0888a9f/nihms346261f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/6c49e8fe91d3/nihms346261f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/ddd14371b841/nihms346261f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e967/3342462/b4f795a7b6fb/nihms346261f6.jpg

相似文献

1
Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.雌激素对 S6K1 表达的调节在控制乳腺癌细胞增殖中形成了一个正反馈调节环。
Oncogene. 2012 Dec 6;31(49):5073-80. doi: 10.1038/onc.2011.657. Epub 2012 Jan 30.
2
S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.S6激酶1在控制乳腺癌细胞增殖过程中调节雌激素受体α 。
J Biol Chem. 2009 Mar 6;284(10):6361-9. doi: 10.1074/jbc.M807532200. Epub 2008 Dec 27.
3
The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.在乳腺癌细胞中,胰岛素样生长因子(IGF)信号通路通过一种依赖核糖体蛋白S6激酶1(S6K1)的机制调节雌激素受体α(ERα)。
Mol Endocrinol. 2011 Mar;25(3):516-28. doi: 10.1210/me.2010-0373. Epub 2011 Feb 3.
4
The role of S6K1 in ER-positive breast cancer.S6K1 在 ER 阳性乳腺癌中的作用。
Cell Cycle. 2012 Sep 1;11(17):3159-65. doi: 10.4161/cc.21194. Epub 2012 Aug 16.
5
mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.在雌激素刺激下,mTORC1直接磷酸化并激活雌激素受体α。
Oncogene. 2016 Jul 7;35(27):3535-43. doi: 10.1038/onc.2015.414. Epub 2015 Nov 2.
6
PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression.PI3K/mTOR 介导乳腺癌有丝分裂原依赖性组蛋白去乙酰化酶 1 的磷酸化:雌激素受体表达的新调控。
J Mol Cell Biol. 2015 Apr;7(2):132-42. doi: 10.1093/jmcb/mjv021. Epub 2015 Mar 23.
7
The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.ERα-miR-575-p27 反馈环路调节 ER 阳性乳腺癌对他莫昔芬的敏感性。
Theranostics. 2020 Aug 29;10(23):10729-10742. doi: 10.7150/thno.46297. eCollection 2020.
8
Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.肾母细胞瘤1抑制基因通过下调乳腺癌细胞中雌激素受体α的表达介导抗雌激素耐药性。
Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.
9
Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.蛋白激酶A在乳腺癌细胞中表现出对雌二醇依赖性转录的选择性调节,这与配体结合减少、雌激素受体α启动子相互作用改变以及受体磷酸化变化有关。
Mol Endocrinol. 2007 Feb;21(2):439-56. doi: 10.1210/me.2006-0059. Epub 2006 Oct 26.
10
FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.FOXC1通过对抗GATA3结合参与雌激素受体α(ERα)沉默,并与内分泌抵抗有关。
Oncogene. 2016 Oct 13;35(41):5400-5411. doi: 10.1038/onc.2016.78. Epub 2016 Apr 4.

引用本文的文献

1
Combined Phytochemical Sulforaphane and Dietary Fiber Inulin Contribute to the Prevention of ER-Negative Breast Cancer via PI3K/AKT/MTOR Pathway and Modulating Gut Microbial Composition.联合植物化学物质萝卜硫素和膳食纤维菊粉通过PI3K/AKT/MTOR途径及调节肠道微生物组成有助于预防雌激素受体阴性乳腺癌。
Nutrients. 2025 Jun 17;17(12):2023. doi: 10.3390/nu17122023.
2
The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.剪接因子SRRM2调节两种S6K激酶以促进结直肠癌生长。
Oncogene. 2025 May;44(18):1284-1299. doi: 10.1038/s41388-025-03307-1. Epub 2025 Feb 16.
3
S6K1 is a Targetable Vulnerability in Tumors Exhibiting Plasticity and Therapy Resistance.

本文引用的文献

1
Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.雌激素诱导的极光激酶-A(AURKA)基因表达受雌激素受体阳性乳腺癌细胞中的 GATA-3 激活。
Horm Cancer. 2010 Feb;1(1):11-20. doi: 10.1007/s12672-010-0006-x. Epub 2010 Feb 20.
2
The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.在乳腺癌细胞中,胰岛素样生长因子(IGF)信号通路通过一种依赖核糖体蛋白S6激酶1(S6K1)的机制调节雌激素受体α(ERα)。
Mol Endocrinol. 2011 Mar;25(3):516-28. doi: 10.1210/me.2010-0373. Epub 2011 Feb 3.
3
Are we missing the mTOR target in breast cancer?
S6K1是具有可塑性和治疗抗性的肿瘤中一个可靶向的弱点。
Int J Biol Sci. 2025 Jan 1;21(2):454-472. doi: 10.7150/ijbs.96672. eCollection 2025.
4
Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics.6-酰胺基-4-氨基异吲哚啉-1,3-二酮作为p70S6K1抑制剂及潜在乳腺癌治疗药物的研发
Front Mol Biosci. 2024 Dec 19;11:1481912. doi: 10.3389/fmolb.2024.1481912. eCollection 2024.
5
GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.GATA3和上皮-间质转化标志物可预测他莫昔芬对雌激素受体阳性乳腺癌的长期疗效。
NPJ Breast Cancer. 2024 Sep 6;10(1):78. doi: 10.1038/s41523-024-00688-6.
6
TMEM97/Sigma 2 Receptor Increases Estrogen Receptor α Activity in Promoting Breast Cancer Cell Growth.跨膜蛋白97/西格玛2受体在促进乳腺癌细胞生长过程中增强雌激素受体α活性。
Cancers (Basel). 2023 Dec 2;15(23):5691. doi: 10.3390/cancers15235691.
7
Regulation of mRNA translation by estrogen receptor in breast cancer.雌激素受体在乳腺癌中对 mRNA 翻译的调控。
Steroids. 2023 Dec;200:109316. doi: 10.1016/j.steroids.2023.109316. Epub 2023 Oct 6.
8
Isolation of Fucoxanthin from Montagne, 1845 Seaweed in Vietnam and Its Neuroprotective Activity.从越南1845年的海藻中分离岩藻黄质及其神经保护活性。
Biomedicines. 2023 Aug 19;11(8):2310. doi: 10.3390/biomedicines11082310.
9
PPM1H is down-regulated by ATF6 and dephosphorylates p-RPS6KB1 to inhibit progression of hepatocellular carcinoma.PPM1H 通过 ATF6 下调并去磷酸化 p-RPS6KB1 抑制肝癌进展。
Mol Ther Nucleic Acids. 2023 Jun 19;33:164-179. doi: 10.1016/j.omtn.2023.06.013. eCollection 2023 Sep 12.
10
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature.HR+/HER2-转移性乳腺癌对CDK4/6抑制剂的耐药机制及反应预测生物标志物——文献综述
Diagnostics (Basel). 2023 Mar 5;13(5):987. doi: 10.3390/diagnostics13050987.
我们是否在乳腺癌中遗漏了mTOR靶点?
Breast Cancer Res Treat. 2011 Aug;128(3):607-11. doi: 10.1007/s10549-010-1207-2. Epub 2010 Oct 16.
4
Functions and regulation of the 70kDa ribosomal S6 kinases.70kDa 核糖体 S6 激酶的功能和调节。
Int J Biochem Cell Biol. 2011 Jan;43(1):47-59. doi: 10.1016/j.biocel.2010.09.018. Epub 2010 Oct 12.
5
Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.哺乳动物雷帕霉素靶蛋白(mTOR):指挥细胞信号交响乐。
J Biol Chem. 2010 May 7;285(19):14071-7. doi: 10.1074/jbc.R109.094003. Epub 2010 Mar 15.
6
mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation.mTOR/S6K1 和 MAPK/RSK 信号通路协同调节雌激素受体α丝氨酸 167 磷酸化。
FEBS Lett. 2010 Jan 4;584(1):124-8. doi: 10.1016/j.febslet.2009.11.041.
7
An oestrogen-receptor-alpha-bound human chromatin interactome.一个与雌激素受体α结合的人类染色质相互作用组。
Nature. 2009 Nov 5;462(7269):58-64. doi: 10.1038/nature08497.
8
Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.聚(ADP-核糖)聚合酶-1和聚(ADP-核糖)糖苷水解酶对MCF-7人乳腺癌细胞转录调控的全局分析
J Biol Chem. 2009 Dec 4;284(49):33926-38. doi: 10.1074/jbc.M109.023879. Epub 2009 Oct 7.
9
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.依维莫司联合来曲唑与安慰剂联合来曲唑作为新辅助治疗雌激素受体阳性乳腺癌患者的II期随机研究。
J Clin Oncol. 2009 Jun 1;27(16):2630-7. doi: 10.1200/JCO.2008.18.8391. Epub 2009 Apr 20.
10
Genetic alterations and oncogenic pathways associated with breast cancer subtypes.与乳腺癌亚型相关的基因改变和致癌途径。
Mol Cancer Res. 2009 Apr;7(4):511-22. doi: 10.1158/1541-7786.MCR-08-0107.